Cite
HARVARD Citation
Baviera, M. et al. (2021). Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon‐like peptide‐1 receptor agonists or sodium‐glucose cotransporter‐2 inhibitors: A real‐world study in two Italian cohorts. Diabetes, obesity & metabolism. 23 (7), pp. 1484-1495. [Online].